Overexpression of coupling factor 6 attenuates exercise-induced physiological cardiac hypertrophy by inhibiting PI3K/Akt signaling in mice

被引:22
|
作者
Sagara, Shigeki [1 ]
Osanai, Tomohiro [1 ]
Itoh, Taihei [1 ]
Izumiyama, Kei [1 ]
Shibutani, Shuji [1 ]
Hanada, Kenji [1 ]
Yokoyama, Hiroaki [1 ]
Yamamoto, Yuko [1 ]
Yokota, Takashi [1 ]
Tomita, Hirofumi [1 ]
Magota, Koji [2 ]
Okumura, Ken [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori 0368562, Japan
[2] Asubio Pharma Co Ltd, Fac Discovery & Biotechnol 2, Chuo Ku, Kobe, Hyogo, Japan
关键词
coupling factor 6; physiological cardiac hypertrophy; phosphatidylinositol 3-kinase/Akt signaling; tissue acidosis; VASCULAR ENDOTHELIAL-CELLS; ATP SYNTHASE; HEART-FAILURE; IGF-I; GROWTH; INCREASES; RAT; COUPLING-FACTOR-6; MITOCHONDRIA; DYSFUNCTION;
D O I
10.1097/HJH.0b013e3283505101
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Regular exercise improves systolic cardiac dysfunction through Akt cascade-mediated physiological hypertrophy in congestive heart failure. Tissue acidosis impairs Akt cascade, and coupling factor 6 induces tissue acidosis via activation of ecto-F1Fo complex. We tested the hypothesis that coupling factor 6 attenuates physiological cardiac hypertrophy induced by exercise and its benefit in mice. Methods and results: Adult wild-type mice (n = 20) and coupling factor 6-overexpressing transgenic mice (n = 20) were divided into two groups with or without 4-week exercise consisting of 90-min swimming twice daily. Left ventricular posterior wall and interventricular septum thicknesses were increased by 0.12 +/- 0.1 and 0.16 +/- 0.1mm, respectively, after 4-week swimming in wild-type mice (both P < 0.01), but unchanged in transgenic mice. Fractional shortening was increased from 37 +/- 1 to 41 +/- 1% after 4-week swimming in wild-type mice (P < 0.05), whereas it was unchanged in transgenic. The insulin-like growth factor 1 (IGF-1) receptor protein and its phosphorylated form in the heart were both increased by 1.83 +/- 0.23 and 1.83 +/- 0.09 times, respectively, after 4-week swimming in wild-type mice (both P < 0.05), but were unchanged in transgenic. Downstream phosphoinsulin receptor substrate 1, phosphoinositide 3-kinase, and phospho-Akt were increased by 2.22 +/- 0.22, 1.78 +/- 0.31, and 2.24 +/- 0.49 times, respectively, in wild-type mice (all P < 0.05), but were unchanged in transgenic. Restoration of phospho-Akt by IGF-1 injection recovered left ventricular hypertrophy and systolic function after 4-week swimming in transgenic. Conclusion: Overexpression of coupling factor 6 attenuates exercise-induced physiological cardiac hypertrophy by downregulating Akt signaling, thereby cancelling its benefit for cardiac function in mice. Reduction in coupling factor 6 level seems to be useful for drawing the exercising effects on cardiac function.
引用
收藏
页码:778 / 786
页数:9
相关论文
共 50 条
  • [31] Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K/Akt/mTOR signaling pathway
    Yang, Wenting
    Pan, Lin
    Cheng, Yiju
    Wu, Xiao
    Huang, Songsong
    Du, Juan
    Zhu, Honglan
    Zhang, Menglin
    Zhang, Yuquan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [32] Glaucocalyxin A alleviates ulcerative colitis by inhibiting PI3K/AKT/mTOR signaling
    Zhou, Tongtong
    Ye, Yujing
    Chen, Weijie
    Wang, Yanyan
    Ding, Lulu
    Liu, Yicun
    Luo, Leilei
    Wei, Lixian
    Chen, Jian
    Bian, Zhaolian
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [33] Ciliary neurotrophic factor attenuates myocardial infarction-induced oxidative stress and ferroptosis via PI3K/Akt signaling
    Wang, Jian
    Wu, Nan
    Zhang, Jie
    Li, Xiaojing
    Hu, Yingchu
    Dai, Jiating
    Shen, Caijie
    Chen, Xiaomin
    JOURNAL OF MOLECULAR HISTOLOGY, 2025, 56 (02)
  • [34] Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90
    Yu, Zhenlong
    Jv, Yanan
    Cai, Lu
    Tian, Xiangge
    Huo, Xiaokui
    Wang, Chao
    Zhang, Baojing
    Sun, ChengPeng
    Ning, Jing
    Feng, Lei
    Zhang, Houli
    Ma, Xiaochi
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 371 : 63 - 73
  • [35] The Correlation of PI3K/Akt Signaling Pathway with the Occurrence of Cardiac Cachexia
    Zhang, Xin
    Fan, Qinmei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C213 - C214
  • [36] Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway
    Zhan, Kai
    Liu, Rui
    Tong, Hang
    Gao, Shun
    Yang, Guang
    Hossain, Arman
    Li, Tinghao
    He, Weiyang
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [37] Study of EGCG induced apoptosis in lung cancer cells by inhibiting PI3K/Akt signaling pathway
    Gu, J-J
    Qiao, K-S
    Sun, P.
    Chen, P.
    Li, Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (14) : 4557 - 4563
  • [38] Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3/PI3K/AKT/NF-κB signaling pathway
    Liu, Huijuan
    Tian, Qin
    Ai, Xiaoyu
    Qin, Yuan
    Cui, Zhanhong
    Li, Meng
    Yang, Jiahuan
    Zhai, Denghui
    Liu, Yanrong
    Chen, Shuang
    Meng, Jing
    Sun, Tao
    Zhou, Honggang
    Yang, Cheng
    ONCOTARGET, 2017, 8 (70) : 115028 - 115040
  • [39] Melatonin attenuates sepsis-induced muscle atrophy by regulating the PI3K/Akt signaling pathway
    Yao, Huiming
    Xie, Qian
    Yang, Yuting
    Zhou, Chaoqi
    Zeng, Zhenguo
    Zhang, Wei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 144
  • [40] Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signaling
    Mehra, Siddharth
    Srinivasan, Supriya
    Singh, Samara
    Zhou, Zhiqun
    Garrido, Vanessa
    Silva, Iago De Castro
    Totiger, Tulasigeri M.
    Dosch, Austin R.
    Dai, Xizi
    Dawra, Rajinder K.
    Jala, Venkatakrishna Rao
    Shi, Chanjuan
    Datta, Jashodeep
    VanSaun, Michael
    Merchant, Nipun
    Nagathihalli, Nagaraj
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2022, 323 (04): : G375 - G386